Image may be NSFW.
Clik here to view.
Lemborexant
E2006
CAS Number: 1369764-02-2
Chemical Name: (1R, 2S) -2 – {[(2,4-dimethylpyrimidin-5-yl) oxy] methyl} -2- (3-fluorophenyl ) N (5-fluoropyridin-2-yl) cyclopropanecarboxamide
Indication: Insomnia
Company: Eisai
Image may be NSFW.
Clik here to view.
Synthesis coming…….watch out
References
- Christopher, John A (2014). “Small-molecule antagonists of the orexin receptors”. Pharmaceutical Patent Analyst 3 (6): 625–638.doi:10.4155/ppa.14.46. ISSN 2046-8954.
- Cristoph Boss, Catherine Ross (2015). “Recent Trends in Orexin Research – 2010 to 2015”. ScienceDirect.doi:10.1016/j.bmcl.2015.05.012.
- Boss, Christoph (2014). “Orexin receptor antagonists – a patent review (2010 to August 2014)”. Expert Opinion on Therapeutic Patents 24 (12): 1367–1381.doi:10.1517/13543776.2014.978859. ISSN 1354-3776.
- AdisInsight. “Lemborexant”. Springer. Retrieved 2015-05-23.
Image may be NSFW.
Clik here to view.
External links
Image may be NSFW. Clik here to view. ![]() |
|
Systematic (IUPAC) name | |
---|---|
(1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide
|
|
Clinical data | |
Legal status |
|
Identifiers | |
CAS Registry Number | 1369764-02-2 |
ATC code | None |
PubChem | CID: 56944144 |
ChemSpider | 34500836 |
Chemical data | |
Formula | C22H20F2N4O2 |
Molecular mass | 410.417 g/mol |
////////
Filed under: Phase2 drugs, Uncategorized Tagged: Lemborexant Image may be NSFW.
Clik here to view.

Clik here to view.

Clik here to view.

Clik here to view.

Clik here to view.

Clik here to view.

Clik here to view.

Clik here to view.
